compounding
Butler holds firm on semaglutide compounding ban
Government says ‘no’, to lifting ban on compounding glucagon-like peptide-1 receptor agonists (GLP-1 RAs) Risks associated with compounded GLP-1 RAs outweigh the benefits of improved access to the medication, Mark …
Petition seeks rethink of GLP-1 RAs compounding ban
Politicians are being urged to reconsider the decision to ban the compounding of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) until supply issues ease Patients are calling for the government’s decision …
Practice precautions in simple and complex compounding
The Pharmacy Board of Australia’s revised Guidelines on compounding of medicines is a timely reminder of the responsibilities of pharmacists when compounding, says PDL The guidelines will take effect from …
Board releases revised compounding guidelines
Updated compounding guidelines to provide greater clarity and direction The Pharmacy Board of Australia has today (Monday 5 August 2024) released its revised Guidelines on compounding of medicines, which will …
Compound issues
Warning issued over compounded wind and colic products The Therapeutic Goods Administration (TGA) has issued a warning that it has received reports of serious side effects in infants given compounded …
WHO issues global warning on fake GLP-1 RAs
WHO Global Surveillance and Monitoring System observes increasing reports of “falsified semaglutide products in all geographic regions” The World Health Organization (WHO) has issued a medical product alert related to …
Ozempic compounding ban no ‘knee-jerk’ reaction
Department defends recommendation to ban the compounding of semaglutide and tirepatide medications Moves to prohibit pharmacists from compounding replicas of Ozempic (semaglutide) and Mounjaro (tirepatide) were not a “knee-jerk response” …
Compounding ban ‘a significant public health concern’
Government urged to roll back its ban on compounding weight loss drugs Banning the compounding of glucagon-like peptide-2 receptor agonists (GLP-1RAs) medications will limit patient access to the weight loss …
Government acts on compounding concerns
Compounding exemptions for diabetes medications, Ozempic and Mounjaro, will be removed from 1 October, minister reveals Compounding pharmacies will be barred from producing replicas of Ozempic (semaglutide) and Mounjaro (tirazapetide) …
Severe reactions linked to ‘compounded’ Ozempic
Patient violently ill and vomiting blood after taking illegally compounded Ozempic from an online pharmacy Products being sold as compounded Ozempic (semaglutide) and Mounjaro (tirzepatide) are being linked to severe side …
TGA urges caution over unsolicited compounding offers
GPs are being advised to “exercise deep caution” when contacted with offers to provide compounded semaglutide Prescribers are being warned by the Therapeutic Goods Administration (TGA) not to be “duped” …
Pragmatic approach needed to Ozempic compounding concerns
TGA should crack down on “rogue pharmacists” rather than rolling out a ban on compounding Ozempic (semaglutide), an obesity expert claims Pragmatism is needed when it comes to regulating the …